Table 4. Top 10 cancer incidence in urban Beijing, China, 2008-2012.
Rank | Both |
Male |
Female |
||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Site | Cases | Incidence (1/105) | % | ASR | Site | Cases | Incidence (1/105) | % | ASR | Site | Cases | Incidence (1/105) | % | ASR | |||
1 | Female breast (C50) | 13,188 | 68.5 | 11.09 | 40.64 | Lung (C33-C34) | 14,482 | 73.97 | 23.96 | 37.04 | Breast (C50) | 13,188 | 68.5 | 22.57 | 40.64 | ||
2 | Lung (C33-C34) | 23,774 | 61.23 | 20 | 29.28 | Colorectum (C18-C21) | 7,946 | 40.59 | 13.15 | 21.08 | Lung (C33-C34) | 9,292 | 48.27 | 15.9 | 22.07 | ||
3 | Colorectum (C18-C21) | 14,458 | 37.23 | 12.16 | 18.47 | Liver (C22) | 5,449 | 27.83 | 9.02 | 15.63 | Colorectum (C18-C21) | 6,512 | 33.83 | 11.15 | 16.05 | ||
4 | Prostate (C61) | 4,012 | 20.49 | 6.64 | 3.38 | Stomach (C16) | 5,195 | 26.53 | 8.59 | 13.36 | Thyroid (C73) | 3,251 | 16.89 | 5.56 | 11.77 | ||
5 | Stomach (C16) | 7,792 | 20.07 | 6.56 | 9.87 | Prostate (C61) | 4,012 | 20.49 | 6.64 | 9.31 | Uterus (C54-C55) | 2,934 | 15.24 | 5.02 | 8.91 | ||
6 | Liver (C22) | 7,481 | 19.27 | 6.29 | 10.29 | Kidney (C64-C66,68) | 3,230 | 16.5 | 5.34 | 9.48 | Stomach (C16) | 2,597 | 13.49 | 4.45 | 6.66 | ||
7 | Uterus (C54-C55) | 2,934 | 15.24 | 2.47 | 8.91 | Bladder (C67) | 3,102 | 15.84 | 5.13 | 7.9 | Ovary (C56) | 2,292 | 11.91 | 3.92 | 7.1 | ||
8 | Kidney (C64-C66,68) | 5,359 | 13.8 | 4.51 | 7.59 | Esophagus (C15) | 2,478 | 12.66 | 4.1 | 6.44 | Kidney (C64-C66,68) | 2,129 | 11.06 | 3.64 | 5.74 | ||
9 | Ovary (C56) | 2,292 | 11.91 | 1.93 | 7.1 | Lymphoma (C81-C85,88,90,96) | 2,129 | 10.87 | 3.52 | 6.35 | Liver (C22) | 2,032 | 10.56 | 3.48 | 5.09 | ||
10 | Thyroid (C73) | 4,266 | 10.99 | 3.59 | 7.67 | Pancreas (C25) | 2,034 | 10.39 | 3.37 | 5.41 | Lymphoma (C81-C85,88,90,96) | 1,724 | 8.96 | 2.95 | 4.97 |
ASR, age-standardized rates.